| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,430 |
3,019 |
$682K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,309 |
9,584 |
$566K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,226 |
6,831 |
$346K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,802 |
5,979 |
$230K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,091 |
2,955 |
$211K |
| 87631 |
|
1,424 |
1,328 |
$105K |
| 87428 |
|
894 |
804 |
$37K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
653 |
598 |
$34K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,088 |
4,892 |
$34K |
| 80053 |
Comprehensive metabolic panel |
3,649 |
2,948 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,205 |
3,365 |
$28K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
875 |
687 |
$24K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
909 |
839 |
$18K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
183 |
166 |
$15K |
| 87276 |
|
1,137 |
975 |
$14K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,618 |
1,379 |
$11K |
| 87275 |
|
1,137 |
975 |
$10K |
| 80061 |
Lipid panel |
451 |
420 |
$6K |
| 80050 |
General health panel |
137 |
129 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
443 |
413 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
606 |
527 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
545 |
435 |
$4K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,444 |
619 |
$4K |
| 81001 |
|
1,279 |
1,091 |
$4K |
| 82553 |
|
402 |
318 |
$3K |
| 86317 |
|
313 |
293 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
40 |
38 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,102 |
2,512 |
$3K |
| 84484 |
|
438 |
345 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
84 |
80 |
$2K |
| 82550 |
|
503 |
399 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
220 |
197 |
$2K |
| 87147 |
|
856 |
796 |
$2K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
73 |
61 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
212 |
108 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
509 |
443 |
$2K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
47 |
40 |
$2K |
| 84439 |
|
223 |
205 |
$2K |
| 82948 |
|
843 |
728 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
54 |
24 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
46 |
40 |
$2K |
| 81025 |
|
410 |
363 |
$975.80 |
| 99222 |
Initial hospital care, per day, moderate complexity |
15 |
13 |
$953.40 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
20 |
14 |
$910.00 |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$836.36 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
99 |
64 |
$792.71 |
| 80306 |
|
93 |
82 |
$782.32 |
| 84443 |
Thyroid stimulating hormone (TSH) |
48 |
43 |
$650.65 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
25 |
13 |
$615.16 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
77 |
65 |
$604.17 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,982 |
1,678 |
$593.68 |
| 99233 |
Prolong inpt eval add15 m |
25 |
12 |
$579.40 |
| 83690 |
|
92 |
80 |
$557.52 |
| 83880 |
|
34 |
27 |
$481.91 |
| 85610 |
|
143 |
108 |
$426.98 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
20 |
13 |
$414.00 |
| 90656 |
|
56 |
46 |
$392.62 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,463 |
2,062 |
$368.03 |
| 0012A |
|
15 |
15 |
$345.51 |
| 82150 |
|
60 |
50 |
$330.87 |
| 83735 |
|
62 |
53 |
$279.68 |
| 71045 |
Radiologic examination, chest; single view |
102 |
84 |
$237.80 |
| 82043 |
|
35 |
31 |
$154.17 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
137 |
113 |
$150.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
13 |
$134.80 |
| 99000 |
|
869 |
778 |
$123.31 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16 |
13 |
$82.21 |
| 85730 |
|
66 |
55 |
$61.32 |
| 81002 |
|
45 |
39 |
$56.61 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
150 |
113 |
$48.48 |
| 85027 |
|
12 |
12 |
$42.96 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
17 |
12 |
$34.81 |
| 36415 |
Collection of venous blood by venipuncture |
420 |
335 |
$2.24 |
| 0240U |
|
13 |
12 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
187 |
138 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
14 |
13 |
$0.00 |
| 82962 |
|
16 |
15 |
$0.00 |
| 3074F |
|
63 |
57 |
$0.00 |
| 1159F |
|
151 |
110 |
$0.00 |
| 3078F |
|
98 |
85 |
$0.00 |
| 1160F |
|
151 |
110 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
26 |
14 |
$0.00 |